Anton Berns

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 9

Top Venues

Molecular oncology

EMBO reports

Cancer research communications

PloS one

Netherlands Cancer Institute

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Netherlands Cancer Institute Jan 01 1986

Netherlands

Senior Group Leader :: Division of Molecular Genetics

Publications

Anton Berns
Academia and society should join forces to make anti-cancer treatments more affordable. Molecular oncology 18 (6) (2024)
Anton Berns
Academia and society should join forces to make anti-cancer treatments more affordable. Molecular oncology 18 (6) (2024)
Anton Berns
Academia and society should join forces to make anti-cancer treatments more affordable. Molecular oncology 18 (6) (2024)
Anton Berns
Academia and society should join forces to make anti-cancer treatments more affordable. Molecular oncology (2024)
Anton Berns
Academia and society should join forces to make anti-cancer treatments more affordable. Molecular oncology 18 (6) (2024)
Jitendra Badhai, Nick Landman, Gaurav Kumar Pandey, Ji-Ying Song, Danielle Hulsman, Oscar Krijgsman, Gayathri Chandrasekaran, Anton Berns, Maarten van Lohuizen
Combined inhibition of EZH2 and FGFR is synergistic in BAP1- deficient malignant mesothelioma. Cancer research communications (2023)
Anton Berns, Ulrik Ringborg, Julio E Celis, Manuel Heitor, Neil K Aaronson, Nancy Abou-Zeid, Hans-Olov Adami, Kathi Apostolidis, Michael Baumann, Alberto Bardelli, René Bernards, Yvonne Brandberg, Carlos Caldas, Fabien Calvo, Caroline Dive, Angelika Eggert, Alexander Eggermont, Carolina Espina, Frederik Falkenburg, Jérôme Foucaud, Douglas Hanahan, Ulrike Helbig, Bengt Jönsson, Mette Kalager, Sakari Karjalainen, Miklós Kásler, Pamela Kearns, Klas Kärre, Denis Lacombe, Francesco de Lorenzo, Françoise Meunier, Gerd Nettekoven, Simon Oberst, Péter Nagy, Thierry Philip, Richard Price, Joachim Schuz, Eric Solary, Peter Strang, Josep Tabernero, Emile Voest
Towards a cancer mission in Horizon Europe: recommendations. Molecular oncology 14 (8) (2021)
Andrej Alendar, Jan-Paul Lambooij, Rajith Bhaskaran, Cesare Lancini, Ji-Ying Song, Huub van Vugt, Margriet Snoek, Anton Berns
Gene expression regulation by the Chromodomain helicase DNA-binding protein 9 (CHD9) chromatin remodeler is dispensable for murine development. PloS one 15 (5) (2020)
Remco Nagel, Ekaterina A Semenova, Anton Berns
Drugging the addict: non-oncogene addiction as a target for cancer therapy. EMBO reports 17 (11) (2016)

Anton Berns.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Anton Berns